---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-057670"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T16:58:44.691187+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ReShape Lifesciences prices $2.6M public offering of 1.05M shares at $2.50/share

## Summary
- Public offering of 1,054,604 shares at $2.50 per share; gross proceeds $2,636,510.
- Since May 30, company has sold $3,642,564 in shares under the ATM offering.
- Combined capital raises reduce remaining ATM capacity to $3,420,926.
- Shares offered via previously effective shelf registration statement (S-3).

## SEC filing metadata
- accession: 0001104659-25-057670
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465925057670/0001104659-25-057670-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465925057670/tm2517509d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-057670
- JSON: https://secwatch.observer/filing/0001104659-25-057670.json
- Plain text: https://secwatch.observer/filing/0001104659-25-057670.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.